首页> 美国卫生研究院文献>other >A Phase II Trial of Vorinostat (Suberoylanilide Hydroxamic Acid -SAHA) in Metastatic Breast Cancer: A California Cancer Consortium Study

【2h】

A Phase II Trial of Vorinostat (Suberoylanilide Hydroxamic Acid -SAHA) in Metastatic Breast Cancer: A California Cancer Consortium Study

机译：伏立诺他（Suberoylanilide异羟肟酸-SAHA）在转移性乳腺癌中的II期试验：加利福尼亚癌症协会的一项研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

PurposeThe primary goal of this trial was to determine the response rate of single-agent vorinostat in patients with metastatic breast cancer. The secondary goals included assessment of time to progression, evaluation of toxicities, and overall survival.

机译：目的该试验的主要目的是确定转移性乳腺癌患者中单药伏立诺他的缓解率。次要目标包括评估进展时间，评估毒性和总体生存率。

著录项

期刊名称 other
作者
Thehang H Luu; Robert J Morgan; Lucille Leong; Dean Lim; Mark McNamara; Jana Portnow; Paul Frankel; David D. Smith; James H. Doroshow; David R Gandara; Ana Aparicio; George Somlo;
展开▼
作者单位

展开▼
年(卷),期 -1(14),21
年度 -1
页码 7138–7142
总页数 11
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. 来自一项艾日布林联合吉西他滨对比紫杉醇联合吉西他滨作为HER2阴性转移性乳腺癌的一线化疗的II期、多中心、随机试验的包含神经病变相关量表的生活质量结果:韩国癌症研究组试验(KCSG BR13-11) [J] . Ji-Yeon Kim, Young-Hyuck Im, Tae-Yong Kim, 癌症（英文版） . 2019,第008期
2. CMAB009联合伊立替康或伊立替康单药二线治疗氟嘧啶和奥沙利铂治疗失败的KRAS野生型转移性结直肠癌患者的研究:一项前瞻性、开放、随机、Ⅲ期试验 [J] . 石远凯, 白丽, 张沂平, 癌症（英文版） . 2020,第007期
3. A phase II trial of vorinostat (suberoylanilide hydroxamic acid) in metastatic breast cancer: a California Cancer Consortium study. [J] . Luu TH, Morgan RJ, Leong L, Clinical cancer research: an official journal of the American Association for Cancer Research . 2008,第21期

机译：伏立诺他（磺酰苯胺基异羟肟酸）在转移性乳腺癌中的II期试验：加利福尼亚癌症协会的一项研究。
4. A Phase I/II study of suberoylanilide hydroxamic acid (SAHA) in combination with trastuzumab (Herceptin) in patients with advanced metastatic and/or local chest wall recurrent HER2-amplified breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1104) [J] . Goldstein Lori J., Zhao Fengmin, Wang Molin, Breast cancer research and treatment. . 2017,第2期

机译：与先进转移和/或局部胸壁复发性HER2-扩增的乳腺癌患者的血管氧化铝羟肟酸（SAHA）与RASTUZIMAB（HERECTIN）组合的I / II类研究：ECOG-丙烯癌研究组的试验（E1104 的）
5. A Phase I/II study of suberoylanilide hydroxamic acid (SAHA) in combination with trastuzumab (Herceptin) in patients with advanced metastatic and/or local chest wall recurrent HER2-amplified breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1104) [J] . Goldstein Lori J., Zhao Fengmin, Wang Molin, Breast cancer research and treatment. . 2017,第2期

机译：与先进的转移和/或局部胸壁复发性HER2-扩增乳腺癌患者的血管氧化铝羟肟酸（SAHA）与曲妥珠单抗（HERECTIN）组合的I / II类研究：EMOG-acrin癌症研究组的试验（E1104 ）
6. EFFECTS OF AN EXPERIMENTAL DRUG, SUBEROYLANILIDE HYDROXAMIC ACID (SAHA), ON ATTACHMENT, SPREADING, AND STIFFNESS OF HUMAN BREAST CANCER CELLS ON SILICON SUBSTRATES [C] . Jeannine S. Strobl, Mehdi Nikkhah, Robert Rhoades, First global congress on nanoengineering for medicine and biology 2010 . 2010

机译：实验药物次戊基内酰胺氢氧酸（SAHA）对人乳腺癌细胞在硅基质上的附着，扩散和刚度的影响
7. The structural requirements of histone deacetylase (HDAC) inhibitors: Suberoylanilide hydroxamic acid (SAHA) analogues modified at C3, C6, and C7 positions enhance selectivity [D] . Choi, Sun Ea 2012

机译：组蛋白脱乙酰基酶（HDAC）抑制剂的结构要求：在C3，C6和C7位置修饰的Suberoylanilide异羟肟酸（SAHA）类似物可提高选择性
8. A Phase I/II Study of Suberoylanilide Hydroxamic Acid (SAHA) in Combination with Trastuzumab (Herceptin) in Patients with Advanced Metastatic and/or Local Chest Wall Recurrent HER2-Amplified Breast Cancer: A trial of the ECOG-ACRIN Cancer [O] . Lori J. Goldstein, Fengmin Zhao, Molin Wang, -1

机译：I / II期Suberoylanilide异羟肟酸（SAHA）与曲妥珠单抗（Herceptin）联合治疗晚期转移性和/或局部胸壁复发性HER2扩增乳腺癌的患者：ECOG-ACRIN癌症试验
9. A Phase II Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) in Metastatic Breast Cancer: A California Cancer Consortium Study [O] . Thehang H. Luu, Robert J. Morgan, Lucille Leong, 2008

机译：转移性乳腺癌中Vorinostat（Suberoylanilide羟肟酸）的II期试验：加州癌症联盟研究

A Phase II Trial of Vorinostat (Suberoylanilide Hydroxamic Acid -SAHA) in Metastatic Breast Cancer: A California Cancer Consortium Study

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅